Brugg B, Matus A
Friedrich Miescher Institute, Basel, Switzerland.
J Cell Biol. 1991 Aug;114(4):735-43. doi: 10.1083/jcb.114.4.735.
The influence of phosphorylation on the binding of microtubule-associated protein 2 (MAP2) to cellular microtubules was studied by microinjecting MAP2 in various phosphorylation states into rat-1 fibroblasts, which lack endogenous MAP2. Conventionally prepared brain MAP2, containing 10 mol of endogenous phosphate per mol (MAP2-P10), was completely bound to cellular microtubules within 2-3 min after injection. MAP2 prepared in the presence of phosphatase inhibitors, containing 25 mol/mol of phosphate (MAP2-P25), also bound completely. However, MAP2 whose phosphate content had been reduced to 2 mol phosphate per mol by treatment with alkaline phosphatase in vitro (MAP2-P2) did not initially bind to microtubules, suggesting that phosphorylation of certain sites in MAP2 is essential for binding to microtubules. MAP2-P10 was further phosphorylated in vitro via an endogenously bound protein kinase activity, adding 12 more phosphates, giving a total of 22 mol/mol. This preparation (MAP2-P10+12) also did not bind to microtubules. Assay of the binding of these preparations to taxol-stabilized tubulin polymers in vitro confirmed that their binding to tubulin depended on the state of phosphorylation, but the results obtained in microinjection experiments differed in some cases from in vitro binding. The results suggest that the site of phosphate incorporation rather than the amount is the critical factor in determining microtubule binding activity of MAP2. Furthermore, the interaction of MAP2 with cellular microtubules may be influenced by additional factors that are not evident in vitro.
通过将处于不同磷酸化状态的微管相关蛋白2(MAP2)显微注射到缺乏内源性MAP2的大鼠-1成纤维细胞中,研究了磷酸化对MAP2与细胞微管结合的影响。常规制备的脑MAP2,每摩尔含有10摩尔内源性磷酸盐(MAP2-P10),注射后2-3分钟内完全与细胞微管结合。在磷酸酶抑制剂存在下制备的MAP2,每摩尔含有25摩尔磷酸盐(MAP2-P25),也完全结合。然而,通过体外碱性磷酸酶处理使其磷酸盐含量降至每摩尔2摩尔磷酸盐的MAP2(MAP2-P2)最初不与微管结合,这表明MAP2中某些位点的磷酸化对于与微管结合至关重要。MAP2-P10通过内源性结合的蛋白激酶活性在体外进一步磷酸化,又添加了12个磷酸盐,总共达到22摩尔/摩尔。这种制剂(MAP2-P10+12)也不与微管结合。对这些制剂与紫杉醇稳定的微管蛋白聚合物的体外结合测定证实,它们与微管蛋白的结合取决于磷酸化状态,但显微注射实验获得的结果在某些情况下与体外结合不同。结果表明,磷酸盐掺入的位点而非数量是决定MAP2微管结合活性的关键因素。此外,MAP2与细胞微管的相互作用可能受到体外不明显的其他因素的影响。